Press release
Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market to grow with Rising Cases of Chronic Diseases
According to a new market research report launched by Inkwood Research, the Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market is evolving at a CAGR of 20.65% over the forecasting period of 2021 and 2028, and is projected to generate a revenue of $3545.9 million by 2028Browse 43 market data Tables and 44 figures spread over 147 Pages, along with in-depth analysis on Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market by Type, End-User, & by Geography
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive market, by assessing major geographies, and is a valuable asset for the existing players, new entrants, and future investors. The study presents a detailed market analysis, with inputs derived from industry professionals across the value chain.
Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market Scenario
Non-alcoholic steatohepatitis (NASH) is a non-alcoholic fatty liver disease (NAFLD). It progresses to severe disorders like hepatocellular carcinoma and cirrhosis. NASH is also estimated to become a major cause of liver transplantation in the coming decade. NAFLD is attributed to several metabolic comorbidities like metabolic syndrome, dyslipidemia. According to the Diabetes Research and Clinical practice report 2020, the global prevalence is projected to be 9.3% in 2019, and is expected to reach 10.2% by 2030 and 10.9% by 2045.
Obesity, a worldwide epidemic, has been on the rise in the last decade. Obesity results in degeneration of articular cartilage, leading to osteoarthritis. In 2016, 38% of adults were overweight, and 13% were obese. The increasing prevalence of diabetes and obesity is projected to increase the global non-alcoholic steatohepatitis (NASH) biomarker market growth. Another important driver is the growing awareness of NAFLD. However, the side-effects and risks associated with NASH therapeutics hinder the market growth.
The Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market report provides data tables and includes charts and graphs for visual analysis.
Request Free Sample Report for Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market by Type, End-User & by Geography: https://www.inkwoodresearch.com/reports/non-alcoholic-steatohepatitis-biomarker-market/#request-free-sample
Market Segmentation
Market by Type
• Oxidative Stress Biomarker
• Serum Biomarker
• Hepatic Fibrosis Biomarker
• Apoptosis Biomarker
• Other Types
Market by End-User
• Diagnostic Lab
• Pharma & CRO Industry
• Hospital
• Academic Research Key
Report Highlights
- The report provides a detailed analysis of the current and future market trends, to identify the investment opportunities
- Market forecasts till 2028, using estimated market values as the base numbers
- Key market trends across the business segments, regions, and country
- Key developments and strategies observed in the market
- Market dynamics such as drivers, restraints, opportunities, and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2028
Companies Profiled
• MERCK & CO
• NOVARTIS AG
• NOVO NORDISK
• BRISTOL -MYERS SQUIBB COMPANY
• VIKING THERAPEUTICS
• ALLERGAN PLC (ACQUIRED BY ABBVIE)
• GENFIT SA
• ASTRAZENECA
• PFIZER INC
• SIEMENS HEALTHINEERS
• ZYDUS CADILA
• MADRIGAL PHARMACEUTICALS
• GILEAD SCIENCES INC
Related Reports
GLOBAL BARIATRIC SURGERY MARKET - Global bariatric surgery market is set to project a CAGR of 9.56% during 2019-2028.
GLOBAL HERNIA REPAIR DEVICES AND CONSUMABLES MARKET - Global hernia repair devices and consumables market is predicted to grow at a CAGR of 3.71% during 2021-2028.
GLOBAL KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS MARKET - Global kidney cancer therapeutics and diagnostics market is anticipated to record a CAGR of 5.52% during 2019-2028.
GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET - Global extra corporeal membrane oxygenation (ECMO) system market is estimated to project a CAGR of 4.74% during 2019-2028.
Inkwood Research
169, Harrison Avenue
Boston, MA 02111
Tel: 1-(857)293-0150
Email: sales@inkwoodresearch.com
Website: www.inkwoodresearch.com
We at Inkwood research provide you with not just consulting services but also with syndicated and customized research reports which help advance your business further.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market to grow with Rising Cases of Chronic Diseases here
News-ID: 2834261 • Views: …
More Releases from Inkwood Research

United States Wood Coatings Market Analysis 2024-2032
Inkwood Research states that the United States Wood Coatings Market is expected to achieve a compound annual growth rate (CAGR) of 5.02% during the forecast period of 2024-2032, with projected revenues reaching $xx million by 2032.
This growth is driven by a combination of factors, including increasing construction activities, rising consumer preference for aesthetically appealing wood products, and advancements in coating technologies.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/united-states-wood-coatings-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
Prominent companies in the…

Rising Uptake of Industry 4.0 to Amp Motion Control Market Growth
As per a new market research report launched by Inkwood Research, the Global Motion Control Market is predicted to reach $26041.29 million by 2032, growing at a CAGR of 5.13% during the forecasting period, 2024-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/global-motion-control-market-forecast-2024-2032/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects…

Rise in Golf Tourism to Elevate Golf Cart Market Growth
As per a new market research report launched by Inkwood Research, the Global Golf Cart Market is expected to grow at a CAGR of 5.68% during the forecasting period, 2024-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/golf-cart-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive market by…

Government Rules to Promote the Growth of the Electric Vehicle Power Inverter Ma …
As per a new market research report launched by Inkwood Research, the Global Electric Vehicle Power Inverter Market is expected to reach $34868.78 million by 2032, growing with a CAGR of 14.36% during the forecasting period, 2024-2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/electric-vehicle-power-inverter-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all…
More Releases for NASH
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non-Alcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023
Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance.
NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…